Advertisement

Laparoscopic Retroperitoneal Lymph Node Dissection: Transperitoneal Approach

  • Nasser Albqami
  • Günter Janetschek
Part of the Recent Advances in Endourology book series (ENDOUROLOGY, volume 7)

Summary

To lower the morbidity of retroperitoneal lymphadenectomy, the procedure was modified over the past 35 years from extended suprahilar to bilateral infrahilar, and subsequently a modified laparoscopic unilateral approach then a nerve-sparing technique was introduced. There was no increase in relapse rates associated with the introduction of these operative refinements; significant factors for relapse were pathological stage (P < 0.001) and adjuvant chemotherapy in stage II disease (P < 0.001) [8]. Laparoscopic retroperitoneal lymph node dissection (RPLND) has been advocated and utilized in the management of testicular cancer over the past decade. This method technically duplicates the open surgical technique and has demonstrated its surgical and oncologic efficacy. The morbidity and complication rates are low. Tumor recurrence rates after laparoscopic RPLND are comparable to those of open surgery. Laparoscopic RPLND is safe, with less postoperative morbidity, quicker convalescence, improved cosmetic results, and a diagnostic accuracy equal to that of the open technique.

Keywords

Testicular cancer Retroperitoneal lymph node dissection Laparoscopy Transperitoneal approach Chemotherapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Steiner H, Peschel R, Janetschek G, Holtl L, Berger AP, Bartsch G, Hobisch A (2004) Long-term result of laparoscopic retroperitoneal lymph node dissection: a singlecenter 10 years experience. Urology 63:550–555CrossRefPubMedGoogle Scholar
  2. 2.
    Corvin S, Kuczyk M, Anastasiadis A, Stenzl A (2004) Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. World J Urol 22:33–36CrossRefPubMedGoogle Scholar
  3. 3.
    Rassweiler JJ, Frede T, Lenz E, Seemann O, Alken P (2000) Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of lowstage testis cancer. Eur Urol 37:251–260CrossRefPubMedGoogle Scholar
  4. 4.
    Bhayani SB, Allaf ME, Kavoussi LR (2004) Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: current status. Urol Oncol 22:145–148PubMedGoogle Scholar
  5. 5.
    Klingler HC, Remzi M, Janetschek G, Marberger M (2003) Benefits of laparoscopic renal surgery are more pronounced in patients with a high body mass index. Eur Urol 43:522–527PubMedGoogle Scholar
  6. 6.
    Weissbach L, Boedefeld EA (1987) Testicular tumour study group: localization of solitary and multiple metastases in stage II non seminomatous testis tumour as basis for modified staging lymph node dissection in stage I. J Urol 138:77–82PubMedGoogle Scholar
  7. 7.
    Richie JP, Kantoff PW (1991) Is adjuvant chemotherapy necessary for patients with stage BI testicular cancer? J Clin Oncol 9:1393–1396PubMedGoogle Scholar
  8. 8.
    Donhue JP, Thornhill JA, Foster RS, Roland RG, Bihrle R (1993) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965–1989): modification of technique and impact on ejaculation. J Urol 149:243–237Google Scholar
  9. 9.
    Williams SD, Stablein DM, Einhorn LH, Muggia FM, Weiss RB, Donohue JP, Paulson DF, Brunner KW, Jacobs EM, Spaulding JT (1987) Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317:1433–1438PubMedGoogle Scholar
  10. 10.
    Javadpour N (1984) Predictors of recurrence in stage II nonseminomatous testicular cancer after lymphadenectomy: implications for adjuvant chemotherapy. J Urol 135:629Google Scholar
  11. 11.
    Castillo O, Urena R, Pinto I, Olivares R, Portalier P (2004) Laparoscopic retroperitoneal lymph node dissection for stage I and II NSGCT. J Urol Suppl number 933, Volum 171, page 247–248.Google Scholar
  12. 12.
    Bhayani SB, Ong A, Oh WK, Kantoff PW, Kavoussi LR (2003) Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: A long-term update. Urology 62:324–327PubMedGoogle Scholar
  13. 13.
    Janetschek G, Hobisch A, Höltl L, Bartsch G (1996) Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: Laparoscopy versus open surgery and impact of learning curve. J Urol 156:89–93PubMedGoogle Scholar
  14. 14.
    Heidenreich A, Albers P, Hartmann M, Kliesch S, Koehrmann K, Krege S, Lossin P, Weissbach L (2003) Complications of nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumours of the testis (Experience of the German testicular cancer study group). J Urol 169:1710–1714CrossRefPubMedGoogle Scholar
  15. 15.
    Rassweiler JJ, Seemann O, Henkel TO, Stock C, Frede T, Alken P (1996) Laparoscopic retroperitoneal lymph node dissection for non seminomatous germ cell tumour: indication and limitation. J Urol 156:1108–1113CrossRefPubMedGoogle Scholar
  16. 16.
    Palese MA, Li-Ming Su, Kavoussi LR (2002) laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 60:130–134CrossRefPubMedGoogle Scholar
  17. 17.
    Steiner H, Holtl L, Wirtenberger W, Berger AP, Bartsch G, Hobisch A (2002) Longterm experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study. Urology 60:324–328CrossRefPubMedGoogle Scholar
  18. 18.
    Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G (1990) Nervesparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144:287–291PubMedGoogle Scholar
  19. 19.
    Whitelaw GP, Smithwick RH (1951) Some secondary effects of sympathectomy with particular reference to disturbance of sexual function. N Engl J Med 245:212Google Scholar
  20. 20.
    Peschel R, Gettman MT, Neururer R, Hobisch A, Bartsch G (2002) Laparoscopic retroperitoneal lymph node dissection: Description of the nerve sparing technique. Urology 60:339–343CrossRefPubMedGoogle Scholar
  21. 21.
    Janetschek G (2001) Laparoscopic RPLND. Urol Clin North Am 28:107–114PubMedGoogle Scholar
  22. 22.
    Ogan K, Lotan Y, Koeneman K, Pearle MS, Cadeddu JA, Rassweiler J (2002) Laparoscopic versus open retroperitoneal lymph node dissection: a cost analysis. J Urol 168:1945–1949PubMedGoogle Scholar
  23. 23.
    Hobisch A, Tönnemann J, Janetschek G (1998) Morbidity and quality of life after open versus laparoscopic retroperitoneal lymphadenectomy for testicular tumour-the patient’s view. In: Jones WG, Appleyard I, Harnden P, Joffe JK (eds) Germ cell tumours VI. John Libbey, London, p 277Google Scholar

Copyright information

© The Japanese Society of Endourology and ESWL 2006

Authors and Affiliations

  • Nasser Albqami
    • 1
  • Günter Janetschek
    • 1
  1. 1.Department of UrologyElisabethinen HospitalLinzAustria

Personalised recommendations